Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Herein, we review the epitope approach to vaccine development, and discuss how knowledge of HLA supertypes might be used as a tool in the development of such vaccines. After reviewing the main structural features of the A2-, A3-, B7-, and B44- supertype alleles, and biological data demonstrating their immunological relevance, we analyze the frequency at which these supertype alleles are expressed in various ethnicities and discuss the relevance of those observations to vaccine development. Next, the existence of five new supertypes (A1, A24, B27, B58, and B62) is reported. As a result, it is possible to account for the predominance of all known HLA class I with only nine main functional binding specificities. The practical implications of this finding, as well as its relevance to understanding the functional implication of MHC polymorphism in humans, are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individual HLA-I alleles are classified into 12 discrete supertypes (52, 53), on the basis of similar peptide-anchor–binding specificities (26, 52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
In the citing paper
“These supertypes together cover most HLA-A and HLA-B alleles found in distinct populations (52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411 · cited 5×
“Independent observations demonstrate that the motif of the mouse class I allele L is identical to the B7-supermotif (Corr et al. 1992; Falk et al. 1991) While the necessary task of fully exploring and cataloging MHC polymorphism continues, we have begun to appreciate the common denominators and similarities hidden wit…”
BackgroundInfluentialRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialGoulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116 · cited 1×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundRefined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodThe Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020 · cited 1×
“The complex of a major histocompatibilty complex (MHC) molecule and a peptidic antigen acts as the ligand recognized by MHC-restricted T cells (Garcia et al. 1999; Germain and Margulies 1993; Yewdell and Bennink 1999).”
BackgroundCrystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K b
Fremont, D. H., Matsumura, M., Stura, E. A., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323877 · Cited by 861 · cited 1×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains ( Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundSette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5586 · Cited by 830 · cited 1×
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationIdentification of self peptides bound to purified HLA-B27
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., & Wiley, D. C. (1991) · Nature · doi:10.1038/353326a0 · Cited by 827 · cited 5×
“Pool sequencing motifs for peptides bound to HLAB*1401-02, B*1503, B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991…”
BackgroundInfluential
Cited by
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science · doi:10.1126/science.aao4572 · Cited by 1,142
Reliable prediction of T‐cell epitopes using neural networks with novel sequence representations
Nielsen, M., Lundegaard, C., Worning, P., Lauemøller, S. L., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2003) · Protein Science · doi:10.1110/ps.0239403 · Cited by 1,074
“All sequences from the database were downloaded and clustered into the nine super-types (A1, A2, A3, A24, B7, B27, B44, B58, and B62) and 3 outlier types (A29, B8, and B46) described by Sette and Sidney (1999).”
MethodHLA class I supertypes: a revised and updated classification
Sidney, J., Peters, B., Frahm, N., Brander, C., & Sette, A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-1 · Cited by 775
Self-citationNielsen, M., Lundegaard, C., Blicher, T., Lamberth, K., Harndahl, M., Justesen, S., Røder, G., Peters, B., Sette, A., Lund, O., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000796 · Cited by 719
“. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (A) Predictors of HLA-A locus molecules (with random negatives) Pan Self Neighbor Supertype Count A0101 0.46 0.88 0.26 A1101 A1 1213 A0201 0.87 0.89 0.82 A0206 A2 3876 A0202 0.81…”
BackgroundResultInfluentialSelf-citationFundamentals and Methods for T- and B-Cell Epitope Prediction
Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017) · Journal of Immunology Research · doi:10.1155/2017/2680160 · Cited by 674
“Interestingly, different HLA molecules can also bind similar sets of peptides [57, 58] and researchers have devised methods to cluster them in groups, known as HLA supertypes, consisting of HLA alleles with similar peptide-binding specificities [59–61].”
BackgroundWeiskopf, D., Angelo, M. A., de Azeredo, E. L., Sidney, J., Greenbaum, J. A., Fernando, A. N., Broadwater, A., Kolla, R. V., De Silva, A. D., de Silva, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305227110 · Cited by 615
Self-citationReverse Vaccinology: Developing Vaccines in the Era of Genomics
Sette, A., & Rappuoli, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.017 · Cited by 559
“Interestingly, the antigens dominantly recognized by antibodies are similar to the ones recognized by CD4+ T cell responses (Jing et al., 2008; Sette et al., 2008).”
BackgroundResultSelf-citationGreenbaum, J., Sidney, J., Chung, J., Brander, C., Peters, B., & Sette, A. (2011) · Immunogenetics · doi:10.1007/s00251-011-0513-0 · Cited by 448
“In the case of HLA class I, several previous studies have demonstrated the existence of HLA supertypes, which define sets of HLA-A and B class I molecules associated with largely overlapping peptide-binding repertoires (Cano et al. 1998; Chelvanayagam 1996; Doytchinova et al. 2004; Hertz and Yanover 2007; Kangueane et…”
BackgroundResultSelf-citationA marker for Stevens-Johnson syndrome …: ethnicity matters
Lonjou, C., Thomas, L., Borot, N., Ledger, N., de Toma, C., LeLouet, H., Graf, E., Schumacher, M., Hovnanian, A., Mockenhaupt, M., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500356 · Cited by 401
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Grifoni, A., Sidney, J., Vita, R., Peters, B., Crotty, S., Weiskopf, D., & Sette, A. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.010 · Cited by 314
“Establishing the extent to which epitope identification studies adequately cover the worldwide population is both a key and 1084 Cell Host & Microbe 29, July 14, 2021 non-trivial issue (Greenbaum et al., 2011; McKinney et al., 2013; Sette and Sidney, 1999).”
Self-citationAdvantage of rare HLA supertype in HIV disease progression
Trachtenberg, E., Korber, B., Sollars, C., Kepler, T. B., Hraber, P. T., Hayes, E., Funkhouser, R., Fugate, M., Theiler, J., Hsu, Y. S., et al. (2003) · Nature Medicine · doi:10.1038/nm893 · Cited by 348
Sidney, J., Assarsson, E., Moore, C., Ngo, S., Pinilla, C., Sette, A., & Peters, B. (2008) · Immunome Research · doi:10.1186/1745-7580-4-2 · Cited by 326
“We can note that proline, the B7-supertype associated position 2 specificity, does appear to be well tolerated in position 2 by B*0801.”
BackgroundMethodInfluentialSelf-citationWeiskopf, D., Bangs, D. J., Sidney, J., Kolla, R. V., De Silva, A. D., de Silva, A. M., Crotty, S., Peters, B., & Sette, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505956112 · Cited by 303
Self-citationPaul, S., Weiskopf, D., Angelo, M. A., Sidney, J., Peters, B., & Sette, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302101 · Cited by 298
Self-citationDefinition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
“Epitope-based vaccines have also been shown to confer protection in animal models (see references in Rodriguez et al. 1998; Sette and Sidney 1999).”
BackgroundMethodResultInfluentialToward a Universal Influenza Virus Vaccine: Prospects and Challenges
Pica, N., & Palese, P. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-120611-145115 · Cited by 284
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach
Nielsen, M., Lundegaard, C., Worning, P., Hvid, C. S., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth100 · Cited by 278
“The peptides were clustered into the nine supertypes (A1, A2, A3, A24, B7, B27, B44, B58 and B62) as described by Sette and Sidney (1999).”
MethodKarosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
“2004 ; Sette and Sidney 1999 ) and extended by applying pan - specific class I predictor ( Nielsen et al .”
BackgroundMethodMacDonald, K. S., Fowke, K. R., Kimani, J., Dunand, V. A., Nagelkerke, N. J. D., Ball, T. B., Oyugi, J., Njagi, E., Gaur, L. K., Brunham, R. C., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315472 · Cited by 269
“These are of obvious significance for vaccine design because the inclusion of “super-epitopes” in vaccines would potentially be immunogenic in large subsets of the population [44].”
BackgroundHLA-B Locus in Caucasian Patients with Carbamazepine hypersensitivity
Alfirevic, A., Jorgensen, A. L., Williamson, P. R., Chadwick, D. W., Park, B. K., & Pirmohamed, M. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.6.813 · Cited by 264
“Therefore, we feel that the analysis of our results by defining HLA-B supertypes, families of B alleles that are grouped according to the peptide binding specificity [18], as suggested by Lonjou and colleagues [15], seems to be an oversimplification.”
ResultAllen, T. M., Altfeld, M., Yu, X. G., O'Sullivan, K. M., Lichterfeld, M., Le Gall, S., John, M., Mothe, B. R., Lee, P. K., Kalife, E. T., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7069-7078.2004 · Cited by 261
“These include the kinetics of pathogen protein production (37, 50, 54), proteasome specificity (14, 47, 60, 68), TAP transport (1), N-terminal trimming (13, 29, 39, 42, 60), MHC binding (52, 58), and TCR availability and affinity (12, 23, 28).”
BackgroundSelf-citationIdentification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
Doolan, D. L., Southwood, S., Freilich, D. A., Sidney, J., Graber, N. L., Shatney, L., Bebris, L., Florens, L., Dobano, C., Witney, A. A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633254100 · Cited by 237
Self-citationMHC Class II epitope predictive algorithms
Nielsen, M., Lund, O., Buus, S., & Lundegaard, C. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03268.x · Cited by 236
Macdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J., Clements, C. S., Kjer-Nielsen, L., Koelle, D. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030066 · Cited by 204
“It has been suggested that there are nine major HLA class I “supertypes,” or clusters of alleles, that each possess a unique broad specificity for common anchor motifs in antigenic peptides (5).”
BackgroundHeiny, A. T., Miotto, O., Srinivasan, K. N., Khan, A. M., Zhang, G. L., Brusic, V., Tan, T. W., & August, J. T. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001190 · Cited by 196
“The supertypes cover a large fraction of the HLA diversity in the human population and antigen epitopes that bind to the supertypes are considered prime candidates for vaccine formulations [20–24].”
BackgroundIn Silico Identification of Supertypes for Class II MHCs
Doytchinova, I. A., & Flower, D. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7085 · Cited by 193
Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans
Assarsson, E., Bui, H.-H., Sidney, J., Zhang, Q., Glenn, J., Oseroff, C., Mbawuike, I. N., Alexander, J., Newman, M. J., Grey, H., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01563-08 · Cited by 193
“ated with the A1, A2, A3, A24, B7, B44 (23, 24, 26) and DR supertypes (28), and”
BackgroundInfluentialSelf-citationHIV-1 Group M Conserved Elements Vaccine
Rolland, M., Nickle, D. C., & Mullins, J. I. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030157 · Cited by 190
“In addition, CE sequences include supertype motifs from all nine supertypes (B7, A3, A2, A24, B44, A1, B27, B62, B58) in both Gag and Pol, providing a population coverage of at least 80%, regardless of ethnicity [47].”
BackgroundLineburg, K. E., Grant, E. J., Swaminathan, S., Chatzileontiadou, D. S. M., Szeto, C., Sloane, H., Panikkar, A., Raju, J., Crooks, P., Rehan, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.006 · Cited by 183
“These residues are critical anchors for HLA-B7 binding (Sette and Sidney, 1999) and suggest that SPR peptide homologs from these seasonal viral strains might bind to the HLA-B7 molecule.”
BackgroundCompatibility counts: MHC-associated mate choice in a wild promiscuous primate
Schwensow, N., Eberle, M., & Sommer, S. (2008) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2007.1433 · Cited by 181
“…indicate that certain MHC alleles functionally overlap due to similar antigen-binding motifs and emphasize the biological relevance of so-called MHC supertypes in disease resistance (Southwood et al. 1998; Sette & Sidney 1999; Trachtenberg et al. 2003; Lund et al. 2004; Schwensow et al. 2007b).”
Weiskopf, D., Angelo, M. A., Bangs, D. J., Sidney, J., Paul, S., Peters, B., de Silva, A. D., Lindow, J. C., Diehl, S. A., Whitehead, S., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02129-14 · Cited by 177
Self-citationDe Groot, A. S., Moise, L., Terry, F., Gutierrez, A. H., Hindocha, P., Richard, G., Hoft, D. F., Ross, T. M., Noe, A. R., Takahashi, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00442 · Cited by 178
“Taken collectively, the nine HLA Class II supertype alleles, along with their respective family members, cover well-over 95% of most HLA types present in human population groups (20), and the six supertype alleles, along with their respective family members, cover over 98% of the human population groups including East…”
BackgroundTransient expression systems for plant-derived biopharmaceuticals
Komarova, T. V., Baschieri, S., Donini, M., Marusic, C., Benvenuto, E., & Dorokhov, Y. L. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.85 · Cited by 176
Immunoinformatics Comes of Age
Korber, B., LaBute, M., & Yusim, K. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020071 · Cited by 175
Schwensow, N., Fietz, J., Dausmann, K. H., & Sommer, S. (2007) · Heredity · doi:10.1038/sj.hdy.6800993 · Cited by 172
“In humans, a new approach to circumvent this problem was recently proposed by classifying MHC alleles to supertypes based on similar antigen-binding motifs (Southwood et al., 1998; Sette and Sidney, 1999; Trachtenberg et al., 2003; Lund et al., 2004).”
BackgroundTCR Recognition of Peptide–MHC-I: Rule Makers and Breakers
Szeto, C., Lobos, C. A., Nguyen, A. T., & Gras, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010068 · Cited by 169
“MHC, for example, for peptides binding to HLA-B*35:01, a P2-Pro is often observed as well as PΩ-Tyr [2,3].”
BackgroundInfluentialmRNA cancer vaccines: Advances, trends and challenges
He, Q., Gao, H., Tan, D., Zhang, H., & Wang, J.-Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.011 · Cited by 165
“HLA I alleles include 9 e 11 common supertypes, of which the coverage rate is 90% 185,186 The TME is composed of immune cells, mesenchymal cells and various cytokines and tissue factors, which play an important role in tumorigenesis and immune escape 187,188 .”
Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview
Lafuente, E., & Reche, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789105162 · Cited by 160
“Subsequently, other more sophisticated computational approaches have emerged to classify HLA I and HLA II alleles, which have served to refine and expand the original supertypes defined by Sette and Sidney [97, 98].”
BackgroundMethodMHCcluster, a method for functional clustering of MHC molecules
Thomsen, M., Lundegaard, C., Buus, S., Lund, O., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0714-9 · Cited by 159
“In 1999, Sette and Sidney proposed the HLA class I supertype concept, proposing that allelic variants within a supertype would share a large functional overlap, and nine such supertypes could cover the HLA class I functional space (Sette and Sidney 1999).”
InfluentialStaneková, Z., & Varečková, E. (2010) · Virology Journal · doi:10.1186/1743-422x-7-351 · Cited by 159
“major ethnicities could be reached [117,132].”
BackgroundInfluentialBihl, F., Frahm, N., Di Giammarino, L., Sidney, J., John, M., Yusim, K., Woodberry, T., Sango, K., Hewitt, H. S., Henry, L., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4094 · Cited by 157
“A previously described HLA binding assay was used to determine binding affinities of all 276 peptides to a total of 16 alleles in the HLA-A02, HLAA03, HLA-B07, and HLA-B58 supertypes (25, 26).”
MethodSelf-citationOptimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
Livingston, B. D., Newman, M. J., Crimi, C., McKinney, D. M., Chesnut, R. W., & Sette, A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00233-x · Cited by 156
Self-citationHe, Y. O., Rappuoli, R., Groot, A. S. D., & Chen, R. T. (2010) · BioMed Research International · doi:10.1155/2010/218590 · Cited by 168
“Fortunately, there is some conservation between HLA pockets, and both DeLisi and Sette have addressed the issue of HLA coverage for epitope predictions by demonstrating that epitope-based vaccines containing epitopes restricted by selected “supertype” Class I and Class II HLA can provide the broadest possible coverage…”
BackgroundTynan, F. E., Borg, N. A., Miles, J. J., Beddoe, T., Elhassen, D., Silins, S. L., van Zuylen, W. J., Purcell, A. W., Kjer‐Nielsen, L., McCluskey, J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503060200 · Cited by 152
T-Cell Immunity to Infection with Dengue Virus in Humans
Weiskopf, D., & Sette, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00093 · Cited by 150
“MHC molecules are extremely polymorphic, with several thousand variants known in humans (26, 27).”
BackgroundSelf-citationStructural topology defines protective CD8 + T cell epitopes in the HIV proteome
Gaiha, G. D., Rossin, E. J., Urbach, J., Landeros, C., Collins, D. R., Nwonu, C., Muzhingi, I., Anahtar, M. N., Waring, O. M., Piechocka-Trocha, A., et al. (2019) · Science · doi:10.1126/science.aav5095 · Cited by 147
Immunity to CRISPR Cas9 and Cas12a therapeutics
Chew, W. L. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1408 · Cited by 147
Oseroff, C., Kos, F. J., Bui, H., Peters, B., Pasquetto, V., Glenn, J., Palmore, T. N., Sidney, J., Tscharke, D. C., Bennink, J. R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506768102 · Cited by 160
Self-citationZhang, L., Udaka, K., Mamitsuka, H., & Zhu, S. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr060 · Cited by 160
Novitsky, V., Gilbert, P. B., Peter, T., McLane, M. F., Gaolekwe, S., Rybak, N., Thior, I., Ndung’u, T., Marlink, R., Lee, T. H., et al. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.882-890.2003 · Cited by 158
“Not all HLA alleles were assigned to the major HLA supertypes (62, 63), i.”
Tang, J., Tang, S. W., Lobashevsky, E. S., Myracle, A. D., Fideli, U., Aldrovandi, G. M., Allen, S. A., Musonda, R. M., & Kaslow, R. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8276-8284.2002 · Cited by 145
“predicting the relative population coverage (58, 60) of epitope-”
BackgroundMULTIPRED: a computational system for prediction of promiscuous HLA binding peptides
Zhang, G. L., Khan, A. M., Srinivasan, K. N., August, J. T., & Brusić, V. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki452 · Cited by 141
“HLA proteins that have small differences in their peptide-binding grooves and share similar peptide-binding specificities are grouped into HLA supertypes ( 7 ,8).”
BackgroundEvidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection
Hraber, P., KUIKEN, C. L., & Yusim, K. (2007) · Hepatology · doi:10.1002/hep.21889 · Cited by 138
Weiskopf, D., Cerpas, C., Angelo, M. A., Bangs, D. J., Sidney, J., Paul, S., Peters, B., Sanches, F. P., Silvera, C. G. T., Costa, P. R., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv289 · Cited by 134
“The peptides synthesized were predicted to bind at least 1 of 27 common HLA class I MHC molecules (Supplementary Table 1), which collectively account for approximately 97% of the HLA-A and HLA-B allelic variation [22].”
BackgroundSelf-citationWolchok, J. D., Weber, J. S., Hamid, O., Lebbé, C., Maio, M., Schadendorf, D., de Pril, V., Heller, K. N., Chen, T., Ibrahim, R. A., et al. (2010) · PubMed · Cited by 151
Doolan, D. L., Southwood, S., Chesnut, R. W., Appella, E., Gomez, E., Richards, A. L., Higashimoto, Y., Maewal, A., Sidney, J., Gramzinski, R. A., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1123 · Cited by 131
“A large majority of all human HLA-A and -B molecules can be classified in one of nine different supertypes (8).”
BackgroundSelf-citationThe pockets guide to HLA class I molecules
Nguyen, A. T., Szeto, C., & Gras, S. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210410 · Cited by 128
Extensive HLA class I allele promiscuity among viral CTL epitopes
Frahm, N., Yusim, K., Suscovich, T. J., Adams, S. D., Sidney, J., Hraber, P., Hewitt, H. S., Linde, C., Kavanagh, D. G., Woodberry, T., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737365 · Cited by 140
Self-citationIdentifiying Human MHC Supertypes Using Bioinformatic Methods
Doytchinova, I. A., Guan, P., & Flower, D. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4314 · Cited by 126
Jørgensen, K. W., Rasmussen, M., Buus, S., & Nielsen, M. (2013) · Immunology · doi:10.1111/imm.12160 · Cited by 134
Modeling the adaptive immune system: predictions and simulations
Lundegaard, C., Lund, O., Keşmir, C., Brunak, S., & Nielsen, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm471 · Cited by 131
“A way of reducing the problem is to group all the different alleles into supertypes in a manner so that all the alleles within a given supertype have roughly the same peptide specificity (Hertz and Yanover, 2007; Lund et al., 2004; Reche and Reinherz, 2004; Sette and Sidney, 1998, 1999).”
Sidney, J., Southwood, S., Mann, D. L., Fernández-Viña, M., Newman, M. J., & Sette, A. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00319-6 · Cited by 122
Self-citationPoland, G. A., Kennedy, R. B., McKinney, B. A., Ovsyannikova, I. G., Lambert, N. D., Jacobson, R. M., & Oberg, A. L. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.007 · Cited by 122
“When considering peptide-based vaccines for potential use in the majority of the population, a relationship between HLA “supertype” alleles associated with overlapping peptide-binding specificities should be considered [98,99].”
BackgroundHost Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire
Tan, A. T., Loggi, E., Boni, C., Chia, A., Gehring, A. J., Sastry, K. S., Goh, V. J., Fisicaro, P., Andreoné, P., Brander, C., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01124-08 · Cited by 129
“The existence of T-cell responses against conserved regions of different virus strains (13, 46) and the reported degeneracy in HLApeptide binding, with identical peptides able to bind multiple HLA class I types (6, 14, 35, 37, 42), support the idea of a substantial overlap between the virus-specific T-cell repertoires…”
BackgroundReche, P. A., & Reinherz, E. L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki357 · Cited by 117
“Interestingly, groups of several HLA molecules (supertypes) can bind largely overlapping sets of peptides (6,7).”
BackgroundThe design and implementation of the immune epitope database and analysis resource
Peters, B., Sidney, J., Bourne, P. E., Bui, H., Buus, S., Doh, G., Fleri, W., Kronenberg, M., Kubo, R. T., Lund, O., et al. (2005) · Immunogenetics · doi:10.1007/s00251-005-0803-5 · Cited by 120
“…al. 2002; Fleckenstein et al. 1999; Flower et al. 2003; Gromme and Neefjes 2002; Hammer et al. 1993; Lauemoller et al. 2000; Lehner 2003;Madden 1995; Margalit and Altuvia 2003; Rammensee 1995; Saveanu et al. 2002; Sette and Sidney 1999; Stevanovic 2002; van der Merwe and Davis 2003; Van Kaer 2002).”
BackgroundSelf-citationToma, A., Haddouk, S., Briand, J.-P., Camoin, L., Gahery, H., Connan, F., Dubois-Laforgue, D., Caillat-Zucman, S., Guillet, J.-G., Carel, J.-C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504230102 · Cited by 116
HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24
Borghans, J. A. M., Mølgaard, A., de Boer, R. J., & Keşmir, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000920 · Cited by 136
“One forth of all epitopes in Table 1 are presented by HLA alleles with a binding motif very similar to HLA-B58 (belonging to the B58 supertype [38]).”
Immunoinformatics: Predicting Peptide–MHC Binding
Nielsen, M., Andreatta, M., Peters, B., & Buus, S. (2020) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-021920-100259 · Cited by 118
Associations between HLA and autoimmune neurological diseases with autoantibodies
Muñiz‐Castrillo, S., Vogrig, A., & Honnorat, J. (2020) · Autoimmunity Highlights · doi:10.1186/s13317-019-0124-6 · Cited by 126
Sette, A., Livingston, B. D., McKinney, D. M., Appella, E., Fikes, J. D., Sidney, J., Newman, M. J., & Chesnut, R. W. (2001) · Biologicals · doi:10.1006/biol.2001.0297 · Cited by 112
Self-citationTEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
Zhang, L., Chen, Y., Wong, H., Zhou, S., Mamitsuka, H., & Zhu, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030483 · Cited by 119
“The pioneering panspecific method for HLA-I is MULTIPRED [21], which shares binding data within HLA-I supertype (a group of MHC molecules sharing similar binding specificities [22]) and trained supertypespecific models to cover many HLA-I molecules.”
MethodPrediction of epitopes using neural network based methods
Lundegaard, C., Lund, O., & Nielsen, M. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.10.011 · Cited by 114
“This way MHC alleles that have a significant overlap in the peptide binding repertoire can be clustered into the same functional group or supertype (Hertz and Yanover 2007; Lund et al. 2004; Reche and Reinherz 2004; Sette and Sidney 1998; Sette and Sidney 1999).”
BackgroundMoise, L., Gutiérrez, A. H., Kibria, F., Martin, R., Tassone, R., Liu, R., Terry, F. E., Martin, B., & Groot, A. S. D. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1061159 · Cited by 113
“39,40 While it may appear that this selection of alleles is limited compared to other epitope-prediction websites, EpiMatrix exploits the observation that families of HLA alleles share specific pocket preferences, 41 mitigating the problem of HLA polymorphism and diminishing the epitope-mapping…”
BackgroundCTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening
Wang, M., Lamberth, K., Harndahl, M. N., Røder, G., Stryhn, A., Larsen, M. V., Nielsen, M., Lundegaard, C., Tang, S. T., Dziegiel, M. H., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.12.038 · Cited by 108
Di Marco, M., Schuster, H., Backert, L., Ghosh, M., Rammensee, H.-G., & Stevanović, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700938 · Cited by 111
“HLA-A and HLA-B alleles: HLA-A*01, -A*02, -A*03, -A*24, -B*07, -B*27, -B*44, -B*58, and -B*62 (57, 58).”
Conservation and Variability of Dengue Virus Proteins: Implications for Vaccine Design
Khan, A. M., Miotto, O., Nascimento, E. J. M., Srinivasan, K. N., Heiny, A. T., Zhang, G., Marques, E. T. A., Tan, T. W., Brusić, V., Salmon, J., et al. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000272 · Cited by 115
“Bioinformatics-based approaches were used to (a) extract all DENV sequences available in public databases, (b) identify and examine the structure-function relationship and distribution in nature of sequences that are highly conserved in the majority of DENVs (referred to as pan-DENV sequences), (c) analyze the variabi…”
MethodAlternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2
Lampen, M. H., Hassan, C., Sluijter, M., Geluk, A., Dijkman, K., Tjon, J. M. L., de Ru, A. H., van der Burg, S. H., van Veelen, P. A., & van Hall, T. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.07.009 · Cited by 107
Optimizing vaccine design for cellular processing, MHC binding and TCR recognition
Sette, A., Newman, M. J., Livingston, B. D., McKinney, D. M., Sidney, J., Ishioka, G. Y., Tangri, S., Alexander, J., Fikes, J. D., & Chesnut, R. W. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.590601.x · Cited by 107
Self-citationNovitsky, V., Rybak, N., McLane, M. F., Gilbert, P. B., Chigwedere, P., Klein, I., Gaolekwe, S., Chang, S., Peter, T., Thior, I., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9210-9228.2001 · Cited by 114
Depla, E., der Aa, A. V., Livingston, B. D., Crimi, C., Allosery, K., Brabandere, V. D., Krakover, J. D., Murthy, S., Huang, M. T. F., Power, S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01505-07 · Cited by 119
“(ii) We selected epitopes restricted to the most common HLA supertypes to increase the potential recognition rate within individuals as well as to provide utility in the genetically diverse global population (47, 53).”
BackgroundMethodSelf-citationPasquetto, V., Bui, H., Giannino, R., Mirza, F., Sidney, J., Oseroff, C., Tscharke, D. C., Irvine, K. R., Bennink, J. R., Peters, B., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5504 · Cited by 124
“A large fraction of HLA class I allomorphs can be assigned into a relatively few supertypes, each characterized by largely overlapping peptide-binding repertoires reflecting consensus structures in the main peptide binding pockets (35).”
BackgroundSelf-citationWeiskopf, D., Yauch, L. E., Angelo, M. A., John, D. V., Greenbaum, J., Sidney, J., Kolla, R. V., Silva, A. D. D., de Silva, A. M., Grey, H. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101970 · Cited by 109
Self-citationLong, B. R., Ndhlovu, L. C., Oksenberg, J. R., Lanier, L. L., Hecht, F. M., Nixon, D. F., & Barbour, J. D. (2008) · Journal of Virology · doi:10.1128/jvi.02449-07 · Cited by 105
“In our study population, 11 persons carried either the HLA-B*57 or the HLA-B*58 allele (Table 1), which form the B*58 supertype (31).”
BackgroundSepil, I., Moghadam, H. K., Huchard, É., & Sheldon, B. C. (2012) · BMC Evolutionary Biology · doi:10.1186/1471-2148-12-68 · Cited by 115
“Therefore a growing body of evidence across taxa highlights the importance of clustering Mhc alleles into functional supertypes and considering these supertypes as the unit of selection [31-34].”
BackgroundWilson, C. C., McKinney, D. M., Anders, M., MaWhinney, S., Forster, J. E., Crimi, C., Southwood, S., Sette, A., Chesnut, R. W., Newman, M. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5611 · Cited by 103
“This can be problematic when allele-specific epitopes are identified, but our focus on HLA supertypes is meant to overcome this potential limitation (23, 48, 82).”
BackgroundSelf-citationRiemer, A. B., Keskin, D. B., Zhang, G., Handley, M., Anderson, K. S., Brusić, V., Reinhold, B. B., & Reinherz, E. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126722 · Cited by 117
A second chance for telomerase reverse transcriptase in anticancer immunotherapy
Zanetti, M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.67 · Cited by 109
Barquera, R., Collen, E., Di, D., Bühler, S., Teixeira, J. C., Llamas, B., Nunes, J. M., & Sanchez‐Mazas, A. (2020) · HLA · doi:10.1111/tan.13956 · Cited by 116
Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model
Kumar, A., Suryadevara, N., Wolf, K. J., Wilson, J. T., DiPaolo, R. J., Brien, J. D., & Joyce, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-69897-w · Cited by 100
Sidney, J., Steen, A., Moore, C., Ngo, S., Chung, J., Peters, B., & Sette, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903655 · Cited by 107
Self-citationDeep convolutional neural networks for pan-specific peptide-MHC class I binding prediction
Han, Y., & Kim, D. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1997-x · Cited by 100
“Sette and Sidney grouped HLA class I (HLA-I) molecules into HLA supertypes using binding specificities characterized by the binding motifs of peptides [2].”
BackgroundWeiskopf, D., Angelo, M. A., Sidney, J., Peters, B., Shresta, S., & Sette, A. (2014) · Journal of Virology · doi:10.1128/jvi.01108-14 · Cited by 90
Self-citationImrie, A. A., Meeks, J., Gurary, A., Sukhbataar, M., Kitsutani, P. T., Effler, P. V., & Zhao, Z. (2007) · Journal of Virology · doi:10.1128/jvi.00330-07 · Cited by 105
“To define the precise location of the epitope within the 15-mer NS5326–340 region, truncated peptides were designed to conform with the binding motif for the MHC superfamily B7, of which HLA B55 is a member (29).”
MethodPrakash, S., Srivastava, R., Coulon, P.-G., Dhanushkodi, N. R., Chentoufi, A. A., Tifrea, D. F., Edwards, R. A., Figueroa, C. J., Schubl, S. D., Hsieh, L., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001438 · Cited by 94
Prediction of promiscuous peptides that bind HLA class I molecules
Brusić, V., Petrovsky, N., Zhang, G., & Bajić, V. B. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01088.x · Cited by 99
Genetic susceptibility to mycobacterial disease in humans
Fernando, S. L., & Britton, W. J. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2006.01420.x · Cited by 105
Chentoufi, A. A., Zhang, X., Lamberth, K., Dasgupta, G., Bettahi, I., Nguyen, A., Wu, M. W., Zhu, X., Mohebbi, A., Buus, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.426 · Cited by 93
“Sette and Sidney (73) defined nine HLA class I supertypes that provide an almost perfect coverage ( 99%) of the entire repertoire of HLA class I molecules.”
BackgroundGroot, A. S. D., Ardito, M. T., McClaine, E. M., Moise, L., & Martin, W. D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.040 · Cited by 93
“Both DeLisi and Sette have addressed the issue of HLA coverage for epitope predictions by demonstrating that epitope-based vaccines that contain epitopes restricted by selected “supertype” HLA can provide the broadest possible coverage of the human population [ 36 ].”
Background
Metadata
- Authors
- Sette, A., & Sidney, J.
- ORCID
- Venue
- Immunogenetics
- Published
- 1999-11
- Volume
- 50
- Issue
- 3-4
- Pages
- 201-212
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2052321000
- Cited by
- 635
- References
- 115
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 25 · 2019: 14 · 2018: 20 · 2017: 19 · 2016: 14 · 2015: 26 · 2014: 26 · 2013: 27 · 2012: 37
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai045241-010, n01ai095362-000)
- National Institute of Allergy and Infectious Diseases (N01 AI-45241, N01-AI-95362)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- HLA-A, HLA-B, MHC polymorphism
- MeSH terms
- Alleles, Amino Acid Sequence, Animals, Epitopes, Humans, Molecular Sequence Data, Polymorphism, Genetic, HLA-A Antigens, HLA-B Antigens, Histocompatibility Antigens Class I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.